Gland B2B Business Model and Growth Strategy
Generic Injectables: Growth Drivers
21
Injectables Segment has Demonstrated the Fastest Growth among Delivery Formats
Increase in the prevalence of
diabetes and other chronic
diseases where treatment is primarily
administered through injectables
Drug Shortages in the
United States: c.40% of the
overall drug shortages between 2014-
18 in the US are in injectables
1
Injectables
LO
4
Source: IQVIA Report, American Society of Health-System Pharmacists (ASHP) website.
2
Convenience and benefits of New
Drug Delivery Systems
("NDDS") like auto injectors, pre-filled
syringes etc.
3
New Market Opportunities:
Heavy investments in the development
of new complex molecules to target new
ailments which are increasingly being
treated via injectables
GLANDView entire presentation